This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q2 FY27 consolidated revenue up 37%, profit after tax up 82%
BALAMINES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts less than Nifty Microcap 250 and 3.3 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the consolidated quarter ended 30 September 2026, revenue rose 37% from the year-ago quarter to Rs 46,759.93 lakh and profit after tax rose 82% to Rs 6,747.20 lakh. Earnings before interest, tax, depreciation and amortisation rose from 17.6% to 21.7% of revenue. Consolidated half-year revenue rose 32% and profit after tax rose 98%. Consolidated half-year operating cash flow was Rs 5,446.30 lakh. The Board noted an SEBI warning letter.
Strong revenue, profit, margin and cash flow support the stock, but the SEBI warning letter leaves a compliance risk.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹467.6 Cr | ₹340.6 Cr | +37.3% |
| Operating profit | ₹84.92 Cr | ₹44.57 Cr | +90.5% |
| Profit after tax | ₹67.47 Cr | ₹37.10 Cr | +81.9% |
| EBITDA margin | 21.7% | 17.6% | +4.2 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.